Summary
2,4-Diamino-6-(bis-2-chloroethyl)aminomethyl pteridine has been synthesized and found to be highly potent against L-1210 mouse leukemia lymphoblasts. A single dose of 5 mg/kg injected 24 h after the tumor inoculation increased the life-span of 50% of mice to more than 200%, while the other 505 of animals were cured.
Similar content being viewed by others
References
Calabresi P, Parks RE Jr (1980) Chemotherapy of neoplastic disease. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. Macmillan, New York, pp 1249–1313
Khaled MA, Benington E, Morin RD (1984) Patent applications covering this compound and its analogs and homologs have been filed through Research Corporation of USA
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khaled, M.A., Morin, R.D., Benington, F. et al. 2,4-Diamino-6-(bis-2-chloroethyl)aminomethyl pteridine. Cancer Chemother. Pharmacol. 13, 73–74 (1984). https://doi.org/10.1007/BF00257116
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00257116